🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Plasmodium vivax represents a major health problem throughout the tropics. ...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00158587
Treatments Being Tested
This study is a single center, prospective, cross-over phase 1 trial. Eight...
Status
Completed
Location
University of Mississippi
Start Date
2020-09-01
Trial ID
NCT04073953
To investigate the comparative tolerability, metabolism and pharmacokinetic...
Status
Completed
Location
University of Mississippi
Start Date
2018-08-17
Trial ID
NCT03934450
Treatments Being Tested
This clinical trial evaluates the advantage of prolonging the therapeutic l...
Status
Completed
Location
Fukayosi Dispensary
Start Date
2017-07-27
Trial ID
NCT03241901
Treatments Being Tested
In the 1950s, the WHO included mass drug administration (MDA) with antimala...
Status
Completed
Location
Kilimanjaro Christian Medical Centre
Start Date
2008-02
Trial ID
NCT00509015
This is a prospective, double-blind, double-dummy, multicenter, comparative...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-30
Trial ID
NCT02216123
Treatments Being Tested
This study specifically seeks to quantify the contribution of relapes to th...
Status
Completed
Location
PNG Institute of Medical Research
Start Date
2009-08
Trial ID
NCT02143934
Treatments Being Tested
The purpose of the study is to assess if the antimalarial drugs Dihydroarte...
Status
Completed
Location
Bu Gia Map Commune Health Station
Start Date
2016-05-20
Trial ID
NCT02788864
Treatments Being Tested
This Phase II study is designed to determine whether a single 600 mg dose o...
Status
Terminated
Location
Bangkok Hospital for Tropical Diseases/Mahidol University
Start Date
2003-09-15
Trial ID
NCT01290601
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501